Daclizumab (trade name Zenapax) is a therapeutic humanized monoclonal antibody. It is used to prevent rejection in organ transplantation, especially in kidney ...
Daclizumab is an immunosuppressant. Immunosuppressants decrease the actions of the body's immune system. Daclizumab is used to prevent the body from rejecting a ...
Compared to placebo, daclizumab HYP was associated with a lower annualized relapse rate (0.21 for the 150 mg dose and 0.23 for the 300 mg dose versus 0.46 for placebo ...
Learn about the prescription medication Zenapax (Daclizumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Full final results of the DECIDE trial show 'impressive efficacy and manageable safety,' with daclizumab HYP, the lead investigator reports.
Daclizumab (also known as Zinbryta) is an injectable drug that is being developed for relapsing remitting MS. It has been submitted for FDA approval following ...
Easy to read patient leaflet for daclizumab. Includes indications, proper use, special instructions, precautions, and possible side effects.
BOSTON -- Daclizumab HYP cut relapse rates and disability progression in multiple sclerosis patients more effectively than interferon beta-1a (Avonex) in a phase III ...
Daclizumab is a humanized monoclonal antibody of the immunoglobulin G1 (IgG1) isotype that binds to the α-subunit (CD25) of the high-affinity interleukin-2 (IL-2 ...
ZENAPAX (daclizumab) is used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids. The recommended dose for ZENAPAX ...